R Pelkonen

1.1k total citations
42 papers, 899 citations indexed

About

R Pelkonen is a scholar working on Pharmacology, Oncology and Clinical Biochemistry. According to data from OpenAlex, R Pelkonen has authored 42 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 12 papers in Oncology and 12 papers in Clinical Biochemistry. Recurrent topics in R Pelkonen's work include Pharmacogenetics and Drug Metabolism (16 papers), Metabolism and Genetic Disorders (12 papers) and Drug Transport and Resistance Mechanisms (11 papers). R Pelkonen is often cited by papers focused on Pharmacogenetics and Drug Metabolism (16 papers), Metabolism and Genetic Disorders (12 papers) and Drug Transport and Resistance Mechanisms (11 papers). R Pelkonen collaborates with scholars based in Finland, United States and United Kingdom. R Pelkonen's co-authors include Eero A. Sotaniemi, H Pirttiaho, P. V. Luoma, J Ahlqvist, Arno J. Arranto, R Fogelholm, Esko A. Nikkilä, EA Sotaniemi, S Sutinen and Vilho V. Myllylä and has published in prestigious journals such as New England Journal of Medicine, Diabetes and Cellular and Molecular Life Sciences.

In The Last Decade

R Pelkonen

41 papers receiving 812 citations

Peers

R Pelkonen
A Breckenridge United Kingdom
E. E. Ohnhaus Switzerland
Rashmi Patwardhan United States
P. V. Luoma Finland
David H. Huffman United States
W. Zilly Germany
L. Skovsted Denmark
D. Kadar Canada
C. H. Kleinbloesem Switzerland
E Jacqz United States
A Breckenridge United Kingdom
R Pelkonen
Citations per year, relative to R Pelkonen R Pelkonen (= 1×) peers A Breckenridge

Countries citing papers authored by R Pelkonen

Since Specialization
Citations

This map shows the geographic impact of R Pelkonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Pelkonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Pelkonen more than expected).

Fields of papers citing papers by R Pelkonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Pelkonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Pelkonen. The network helps show where R Pelkonen may publish in the future.

Co-authorship network of co-authors of R Pelkonen

This figure shows the co-authorship network connecting the top 25 collaborators of R Pelkonen. A scholar is included among the top collaborators of R Pelkonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Pelkonen. R Pelkonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Välimäki, Matti, et al.. (1991). Hormonal changes in severely uncontrolled type 1 (insulin-dependent) diabetes mellitus. Scandinavian Journal of Clinical and Laboratory Investigation. 51(4). 385–393. 21 indexed citations
2.
Sane, T, et al.. (1990). Adjustment of insulin doses of diabetic patients during long distance flights.. BMJ. 301(6749). 421.2–422. 17 indexed citations
3.
Aro, J., Reijo Haapiainen, T Sane, et al.. (1990). Effects of Orchiectomy and Polyestradiol Phosphate Therapy onSerum Lipoprotein Lipids and Glucose Tolerance inProstatic Cancer Patients. European Urology. 17(3). 229–235. 10 indexed citations
4.
Sotaniemi, Eero A., et al.. (1987). Enzyme Induction in Man. Medical Entomology and Zoology. 5 indexed citations
5.
Sotaniemi, Eero A., Onni Niemelä, Leila Risteli, et al.. (1986). Fibrotic process and drug metabolism in alcoholic liver disease. Clinical Pharmacology & Therapeutics. 40(1). 46–55. 23 indexed citations
6.
Luoma, P. V., Eero A. Sotaniemi, R Pelkonen, & H Pirttiaho. (1985). Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes. European Journal of Clinical Pharmacology. 28(6). 615–618. 28 indexed citations
7.
Sotaniemi, EA, et al.. (1984). Drug metabolism in diabetic subjects with fatty livers.. British Journal of Clinical Pharmacology. 18(6). 895–899. 17 indexed citations
8.
Luoma, P. V., Eero A. Sotaniemi, & R Pelkonen. (1983). Inverse relationship of serum LDL cholesterol and the LDL/HDL cholesterol ratio to liver microsomal enzyme induction in man.. PubMed. 42(1). 173–6. 8 indexed citations
9.
Sotaniemi, Eero A., S Sutinen, Arno J. Arranto, et al.. (1983). Liver Damage in Nurses Handling Cytostatic Agents. Acta Medica Scandinavica. 214(3). 181–189. 45 indexed citations
10.
Sotaniemi, Eero A., Sirkka Sutinen, Arno J. Arranto, & R Pelkonen. (1982). Surface density of smooth endoplasmic reticulum in hepatocytes and drug metabolism in man. Clinical Pharmacology & Therapeutics. 31(2). 271–272. 3 indexed citations
11.
Sotaniemi, Eero A., et al.. (1982). Liver Injury in Subjects Occupationally Exposed to Chemicals in Low Doses. Acta Medica Scandinavica. 212(4). 207–215. 40 indexed citations
12.
Sotaniemi, EA, et al.. (1980). Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.. British Journal of Clinical Pharmacology. 9(4). 399–405. 13 indexed citations
13.
Luoma, P. V., Eero A. Sotaniemi, R Pelkonen, & Vilho V. Myllylä. (1980). Plasma high-density lipoprotein cholesterol and hepatic cytochrome P-450 concentrations in epileptics undergoing anticonvulsant treatment. Scandinavian Journal of Clinical and Laboratory Investigation. 40(2). 163–167. 52 indexed citations
14.
Sotaniemi, Eero A., et al.. (1980). The evaluation of the drug-metabolizing capacity in patients with diabetes mellitus. Diabetes. 29(10). 788–794. 15 indexed citations
15.
Sotaniemi, Eero A., et al.. (1979). Plasma clearance of propranolol and sotalol and hepatic drug‐metabolizing enzyme activity. Clinical Pharmacology & Therapeutics. 26(2). 153–161. 36 indexed citations
16.
Sotaniemi, Eero A., R Pelkonen, Jorma T. Ahokas, H Pirttiaho, & Johan Ahlqvist. (1978). Relationship between in vivo and in vitro drug metabolism in man. European Journal of Drug Metabolism and Pharmacokinetics. 3(1). 39–45. 34 indexed citations
17.
Pirttiaho, H, et al.. (1978). Liver size and indices of drug metabolism in alcoholics. European Journal of Clinical Pharmacology. 13(1). 61–67. 34 indexed citations
18.
Sotaniemi, Eero A., J Ahlqvist, R Pelkonen, H Pirttiaho, & P. V. Luoma. (1977). Histological changes in the liver and indices of drug metabolism in alcoholics. European Journal of Clinical Pharmacology. 11(4). 295–303. 65 indexed citations
19.
Arvela, P., Niilo T. Kärki, & R Pelkonen. (1976). Lipoperoxidation rates and drug-oxidizing enzyme activities in the liver and placenta of some mammal species during the perinatal period. Cellular and Molecular Life Sciences. 32(10). 1311–1313. 8 indexed citations
20.
Pelkonen, R. (1963). PLASMA VITAMIN A AND E IN THE STUDY OF LIPID AND LIPOPROTEIN METABOLISM IN CORONARY HEART DISEASE.. PubMed. 174. SUPPL399:1–101. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026